Coagulation and Cancer
Author Information
Author(s): J.C. Murray
Primary Institution: CRC Gray Laboratory, Endothelial Biology Group
Hypothesis
Manipulating the blood supply may represent a potential therapeutic approach for solid tumors.
Conclusion
The study highlights the complex relationship between coagulation abnormalities and cancer, suggesting potential therapeutic implications.
Supporting Evidence
- Abnormalities of at least five standard coagulation tests were found in 88 out of 108 cancer patients.
- Elevated levels of fibrin and fibrinogen degradation products were common in cancer patients.
- Many tumor cell lines release tissue factor-like substances that enhance clotting activity.
Takeaway
Cancer can mess with your blood's ability to clot, which might help the cancer spread, but understanding this could lead to new treatments.
Methodology
The article summarizes clinical and experimental evidence regarding the association between clotting abnormalities and cancer.
Limitations
The understanding of coagulation mechanisms in tumors is still incomplete.
Participant Demographics
The study references cancer patients, including those with gastric carcinoma and acute leukaemias.
Want to read the original?
Access the complete publication on the publisher's website